B O O K - American College of Rheumatology

ACR/ARHP Poster Session C
1988. Characterization of Single Histone Deacetylase Isoforms
in Endothelial Cells Derived from Progenitors in Systemic
Sclerosis. Hossein Hemmatazad 1 , Britta Maurer 1 , Beat A.
Michel 1 , Renate E. Gay 1 , Gay Steffen 1 , Jèrome Avouac 2 , Oliver
Distler 1 , Yannick Allanore 2 and Astrid Jüngel 1 , 1 Center of
Experimental Rheumatology, University Hospital and Zurich
Center of Integrative Human Physiology (ZIHP), Zurich,
Switzerland, 2 Department of Rheumatology A, Cochin Hospital,
Universitè Paris Descartes, INSERM U781, Paris, France.
1989. Circulating T Cell Polarization Is Associated with Respiratory
Decline in Scleroderma Patients with Active Interstitial Lung
Disease. Francesco Boin 1 , Fredrick Wigley 2 , Robert Wise 2 and
Antony Rosen 2 , 1 Johns Hopkins University, Baltimore, MD,
2
Johns Hopkins University.
1990. Does Treatment with Imatinib Modify Gene Expression in the
Skin and Peripheral Blood Mononuclear Cells of Patient with
Systemic Sclerosis? Jessica K. Gordon 1 , Robert Spiera 2 , Jamie
N. Mersten 1 , Horatio F. Wildman 4 , Ziad Taimeh 3 , Neil Hackett 4 ,
Sasa Vukelic 3 , Kyriakos A. Kirou 1 and Mary K. Crow 1 , 1 Hospital for
Special Surgery, New York, NY, 2 Hospital for Special Surgery, New
York, NY, 3 Hospital for Special Surgery, 4 Weill-Cornell Medical
College.
1991. Enhanced Expression of Ephrins and Thrombospondins in
the Dermis of Patients with Early Diffuse Systemic Sclerosis:
Potential Contribution to Perturbed Angiogenesis and Fibrosis.
Jerome Avouac 6 , Maud Clemessy 2 , Jorg H. W. Distler 8 , Jean
Marie Gasc 2 , Barbara Ruiz 1 , Marie Cecile Vacher-Lavenu 3 ,
Julien Wipff 6 , Andre Kahan 4 , Catherine Boileau 7 , Pierre Corvol 2
and Yannick Allanore 5 , 1 INSERM U781, Necker Hospital, Paris,
France, 2 INSERM U833 and Collège de France, Paris, France,
3
Paris Descartes University, Pathophysiology Department,
Cochin Hospital, Paris, France, 4 Paris Descartes University,
Rheumatology A Department, Cochin Hospital, APHP,
Paris, France, 5 Paris Descartes University, Rheumatology A
Department, Cochin Hospital, APHP, Paris and INSERM U781,
Necker Hospital, Paris, France, 6 Paris Descartes University,
Rheumatology A Department, Cochin Hospital, APHP, Paris
and INSERM U781, Necker Hospital, Paris, France, 7 U.V.S.Q
University, Biochemistry, Hormonology and Molecular Genetics
Department, Ambroise Paré Hospital, AP-HP, Boulogne, France,
8
University of Erlangen, Erlangen, Germany.
1992. Enhanced IL-17A and IL-22 Production by Peripheral Blood
Mononuclear Cells Distinguish Systemic Sclerosis from Healthy
Individuals. Nicolò C. Brembilla 1 , Marie-Elise Truchetet 2 ,
Elisa Montanari 1 , Yannick Allanore 3 and Carlo Chizzolini 1 ,
1
Immunology & Allergy, Geneva University Hospital, Geneva,
Switzerland, 2 Immunology Allergy, Geneva University Hospital,
Geneva, Switzerland, 3 Rheumatology, Cochin Hospital, Paris,
Paris, France.
1993. Gd Compounds Signaling through Toll-Like Receptors 4
and 7 in Normal Human Macrophages: Establishment of
a Proinflammatory Phenotype and Implications for the
Pathogenesis of Nephrogenic Systemic Fibrosis. Peter J.
Wermuth 1 and Sergio A. Jimenez 2 , 1 Jefferson Institute of
Molecular Medicine and Division of Connective Tissue Diseases,
Thomas Jefferson University, Philadelphia, PA, 2 Thomas
Jefferson Univ, Philadelphia, PA.
1994. Genome-Wide Association Study in Systemic Sclerosis. Yannick
Allanore 5 , Mohammad Saad 2 , Philippe Dieudé 4 , Catherine
Boileau 1 , Maria Martinez 3 and GENESYS Consortium, 1 Biochimie
A. Paré Hospital, Université VSQ, Boulogne, France, 2 INSERM
U563 Université Paul Sabatier, Toulouse, France, 3 NSERM U563
Université Paul Sabatier, Toulouse, France, 4 Rhumatologie,
Inserm u699, Bichat, Paris Diderot Universite, France,
5
Université Paris Descarte, Rhumatologie A, INSERM U781,
Paris, Paris, France.
1995. High Resolution Magnetic Resonance Imaging for the
Assessment of Dermal Fibrosis in a Pre-Clinical Model of
Scleroderma. Helen Jones 1 , Emma Derrett-Smith 1 , Chris P.
Denton 1 , David Abraham 1 , George Bou-Gharios 2 and Po-Wah
So 3 , 1 Centre for Rheumatology, UCL Medical School, 2 Kennedy
Institute of Rheumatology, Imperial College London, 3 Pre-clinical
Imaging Unit, Institute of Psychiatry, King’s College London.
1996. IL-6 Overexpression in Early dcSSc Associates with Poor Clinical
Outcome and May Drive Fibrotic Response. Korsa Khan 1 ,
Shiwen Xu 1 , Christopher P. Denton 2 and Voon Ong 1 , 1 Center for
Rheumatology and Connective Tissue Diseases, UCL Medical
School, Royal Free Hospital, London, United Kingdom, 2 Royal
Free Hospital, London, United Kingdom.
1997. Imatinib Mesylate and Rottlerin Abrogate Transforming
Growth Factor-β Induction of Endothelial-to-Mesenchymal
Transition in Primary Lung Endothelial Cells. Zhaodong Li and
Sergio A. Jimenez, Jefferson Institute of Molecular Medicine,
Thomas Jefferson Univ, Philadelphia, PA.
1998. In Systemic Sclerosis, Cooperation between B-Cells and Skin
Fibroblasts Promotes Fibrogenic Cytokines and Collagen
Production. Antoine Francois 3 , Dominique Wachsmann 3 , Jean
Sibilia 1 and Jacques E. Gottenberg 2 , 1 Strasbourg Hospitals,
Illkirch Graffenstaden, France, 2 Strasbourg Hospitals, Strasbourg,
France, 3 Universite de Strasbourg, Illkirch Graffenstaden, France.
1999. Inhibition of Glycogen Synthase Kinase (GSK)-3β
Downregulates Collagen I Gene Expression in Normal and
Scleroderma Fibroblasts and Abrogates the Profibrotic Effects
of Transforming Growth Factor β (TGF-β). Jolanta Fertala and
Sergio A. Jimenez, Jefferson Institute of Molecular Medicine,
Thomas Jefferson University, Philadelphia, PA.
2000. Insights into the Pathogenesis of Systemic Sclerosis
Vasculopathy Based on Gene Expression Profile of Endothelial
Cells Issued from Progenitors. Jerome Avouac 5 , Nicolas
Cagnard 1 , Jorg H. W. Distler 6 , Yoland Schoindre 2 , Barbara Ruiz 2 ,
Catherine Boileau 2 , Gilles Chiocchia 3 and Yannick Allanore 4 ,
1
INSERM U567, Cochin Hospital, APHP, Paris, France, 2 INSERM
U781, Necker Hospital, Paris, France, 3 NSERM U567, Cochin
Hospital, APHP, Paris, France, 4 Paris Descartes University,
Rheumatology A Department, Cochin Hospital, APHP, Paris and
INSERM U781, Necker Hospital, Paris, France, 5 Paris Descartes
University, Rheumatology ADdepartment, Cochin Hospital,
APHP, Paris and INSERM U781, Necker Hospital, 6 University of
Erlangen, Erlangen, Germany.
2001. PDGF Receptor as Therapeutic and Diagnostic Target in
Systemic Sclerosis. Gianluca Moroncini 4 , Antonella Grieco 5 ,
Chiara Paolini 5 , Giulia Nacci 3 , Massimiliano Cuccioloni 2 , Matteo
Mozzicafreddo 2 , Cecilia Tonnini 5 , Katarzyna Pozniak 5 , Silvia
Svegliati 5 , Mauro Angeletti 2 , Enrico Avvedimento 1 , Ada Funaro 3
and Armando Gabrielli 5 , 1 Dipartimento di Biologia e Patologia
Molecolare e Cellulare, Università Federico II, Napoli, Italy,
2
Dipartimento di Biologia Molecolare, Cellulare e Animale,
Università di Camerino, Italy, 3 Dipartimento di Genetica, Biologia
e Biochimica, Università di Torino, Italy, 4 Dipartimento di Scienze
Mediche e Chirurgiche, Clinica Medica, Università Politecnica
delle Marche, Ancona, Italy, 5 Dipartimento di Scienze Mediche e
Chirurgiche, Clinica Medica, Università Politecnica delle Marche,
Ancona, Italy.
2002. Proteomic Analysis of Systemic Sclerosis Serum Identifies the
Toll-Like Receptor Agonists S100A8/A9 as a Novel Possible
Pathogenic Marker. Lenny van Bon 3 , Arnoud Loof 3 , Helmut
Wittkowski 1 , Waander van Heerde 3 , Madelon Vonk 3 , Johannes
Roth 1 , Wim B. Van Den Berg 2 , Peter van Lent 3 and Timothy
Radstake 3 , 1 Interdisciplinary Centre for Clinical Research
University of Muenster, 2 Radboud Univ Nijmegen Med Cntr,
Nijmegen, The Netherlands, 3 Radboud University Medical
Centre Nijmegen, The Netherlands.
2010 Program Book 273